May, Jan-Niklas http://orcid.org/0000-0003-0327-6267
Moss, Jennifer I.
Mueller, Florian http://orcid.org/0000-0002-9496-4710
Golombek, Susanne K.
Biancacci, Ilaria
Rizzo, Larissa
Elshafei, Asmaa Said
Gremse, Felix
Pola, Robert
Pechar, Michal
Etrych, Tomáš http://orcid.org/0000-0001-5908-5182
Becker, Svea
Trautwein, Christian http://orcid.org/0000-0003-2762-8247
Bülow, Roman D. http://orcid.org/0000-0002-8527-7353
Boor, Peter http://orcid.org/0000-0001-9921-4284
Knuechel, Ruth
von Stillfried, Saskia http://orcid.org/0000-0002-5260-8494
Storm, Gert
Puri, Sanyogitta
Barry, Simon T. http://orcid.org/0000-0002-8511-0588
Schulz, Volkmar
Kiessling, Fabian http://orcid.org/0000-0002-7341-0399
Ashford, Marianne B. http://orcid.org/0000-0001-5301-4607
Lammers, Twan http://orcid.org/0000-0002-1090-6805
Article History
Received: 10 October 2022
Accepted: 8 February 2024
First Online: 8 April 2024
Competing interests
: J.I.M., S.P., S.T.B. and M.B.A. are employees, former employees and shareholders of AstraZeneca PLC. I.B. is employed by Nanomi; the opinions expressed here are her own and do not reflect those of Nanomi. F.G. is the owner of Gremse-IT, which has licensed the image analysis software IMALYTICS Preclinical.